Biaxin, Clarithromycin News

Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, today announced the introduction of Omeclamox-PakA , a ten-day therapy of omeprazole delayed-release capsules , clarithromycin tablets and amoxicillin capsules for the treatment of Helicobacter pylori infection and duodenal ulcer disease to eradicate H. pylori in adult ... (more)

An antibiotic frequently used to treat pneumonia and bronchitis is linked to a higher risk of sudden death in adults, particularly those with heart conditions, a new study reveals.

A macrolide antimicrobial drug was administered to a newborn with cough. On day 23 of hospitalization, macrolide-resistant Bordetella pertussis was isolated from nasopharyngeal aspirates.

Azithromycin one of the most popular medications prescribed to treat bacterial infections such as bronchitis, pneumonia, and infections of the ears, lungs, skin and throat previously believed to carry a small or no cardiac risk is now found to significantly increase the risk of sudden cardiac death.

Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.